Lung cancer screening: the radiologist's perspective.

Area of Science:

• Oncology
• Radiology
• Public Health

Background:

• Lung cancer is the leading cause of cancer death globally, with low early-stage diagnosis rates and poor survival.
• Previous chest X-ray screening trials failed to demonstrate survival benefits for high-risk individuals.
• The National Lung Screening Trial (NLST) showed low-dose CT screening reduces lung cancer and all-cause mortality.

Purpose of the Study:

• To review the evidence for low-dose CT lung cancer screening.
• To address key questions regarding screening implementation, patient selection, and risk-benefit analysis.
• To discuss challenges and costs associated with lung cancer screening programs.

Main Methods:

• Review of randomized controlled trials, including the NLST and European studies.
• Analysis of lung cancer-specific and all-cause mortality data.
• Discussion of clinical and logistical considerations for screening programs.

Main Results:

• The NLST demonstrated a significant survival benefit from low-dose CT screening.
• Contrasting European trials have not yet reproduced these favorable outcomes.
• Unanswered questions persist regarding optimal screening frequency, workup protocols, radiation exposure, and incidental findings.

Conclusions:

• Low-dose CT lung cancer screening shows promise but requires further validation through additional trials.
• Standardizing screening protocols and addressing logistical and cost factors are crucial for effective implementation.
• Ongoing research is essential to clarify the role of CT screening in reducing lung cancer mortality.